Table 1.
Demographic and clinical information at baseline
| Value At baseline | CHR-NP (n = 127) | CHR-P (n = 33) | HC(n = 96) | Statistic | P | |
|---|---|---|---|---|---|---|
| Age (years) | 18.9 ±5.0 | 19.3 ± 5.1 | 18.6 ± 4.5 | F = 0.24 | 0.79 | |
| Education (years) | 10.7 ±3.0 | 10.1 ± 1.9 | 10.9 ± 2.3 | F = 1.02 | 0.36 | |
| Sex (M/F) | 59 / 68 | 22/11 | 51 / 45 | X2 = 4.43 | 0.11 | |
| Scale of Prodromal symptoms | Positive | 10.2 ± 3.5 | 10.3 ± 3.5 | T = −0.2 | −0.84 | |
| Negative | 11.5 ±6.1 | 12.5 ± 6.1 | T = −0.77 | 0.44 | ||
| Disorganization | 6.6 ±3.2 | 6.6 ± 3.3 | T = 0.08 | 0.93 | ||
| General | 9.3 ±3.2 | 8.7 ± 3.2 | 0.95 | 0.34 | ||
| Maximum Global Assessment of Functioning Scale in the past 12 months | 77.2 ±4.9 | 77.4 ± 2.9 | 80.8 ± 1.9 | F = 25.3 | <0.0001 | |
| Global Assessment of Functioning Scale - current | 53.6 ±8.2 | 52.8 ± 7.3 | 80.4 ± 2.2 | F = 517.9 | <0.0001 | |
| Number of subjects with medication more than a month | 3 subjects | 2 subjects | - | |||
| Absolute motion in dMRI | 0.66 ± 0.29 | 0.63 ± 0.22 | 0.64 ± 0.32 | F = 0.42 | 0.66 | |
| Relative motion in dMRI | 0.30 ± 0.14 | 0.29 ± 0.11 | 0.30 ± 0.13 | F = 0.22 | 0.80 | |